CordenPharma Company Profile

20:17 EDT 19th June 2018 | BioPortfolio

News Articles [6 Associated News Articles listed on BioPortfolio]

CordenPharma Expands API Mfg. Capabilities

Announces commercial oligonucleotide API manufacturing expansion in CordenPharma Colorado

CordenPharma ups oligo API capacity at ex-Roche site

CordenPharma has expanded its oligonucleotide active pharmaceutical ingredient manufacturing capacity in Colorado, US.

CordenPharma announces revamped executive leadership team

CordenPharma Appoints New Executive Team

The new CEO, COO, and CFO have over eight decades of experience combined

Outsourcing-Pharma’s Hiring and Firing Roundup February ‘18

CordenPharma has revamped its executive leadership team, Recipharm has named the head of its new global development organization, and several new CEOs have been appointed.

CordenPharma expands oligonucleotide API manufacturing

The expansion, which was completed in Q1 2018, will make the Colorado, US site one of the largest oligonucleotide manufacturing sites worldwide

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


More Information about "CordenPharma" on BioPortfolio

We have published hundreds of CordenPharma news stories on BioPortfolio along with dozens of CordenPharma Clinical Trials and PubMed Articles about CordenPharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CordenPharma Companies in our database. You can also find out about relevant CordenPharma Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record